Tobias Feuchtinger Selected Research

Tobias Feuchtinger Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 09/2011
13	Infections 01/2022 - 03/2004
9	Leukemia 01/2020 - 05/2004
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 07/2014
7	Virus Diseases (Viral Diseases) 01/2022 - 07/2006
7	Adenoviridae Infections (Adenovirus Infections) 09/2015 - 02/2005
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 05/2004
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 11/2004
3	Residual Neoplasm 01/2022 - 07/2014
3	Viremia 03/2015 - 11/2010
2	Vomiting 01/2020 - 11/2019
2	Invasive Fungal Infections 07/2017 - 06/2017
2	Inflammation (Inflammations) 10/2014 - 09/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2022
1	Nasopharyngeal Carcinoma 02/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Glucocorticoid Receptor Deficiency 01/2020
1	Nausea 11/2019
1	Medulloblastoma 01/2019
1	Cardiotoxicity 01/2019
1	Neuroblastoma 01/2018
1	Human Influenza (Influenza) 01/2018
1	Nijmegen Breakage Syndrome 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2018
1	Cytopenia 01/2018
1	Bone Marrow Failure Disorders 01/2018
1	Sickle Cell Anemia (Hemoglobin S Disease) 08/2017
1	Neutropenia 06/2017
1	Bacteremia 01/2016
1	Sepsis (Septicemia) 01/2016
1	Bronchiolitis Obliterans Syndrome 08/2015
1	Testicular Neoplasms (Testicular Cancer) 05/2015
1	Philadelphia Chromosome 07/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	Ewing Sarcoma (Sarcoma, Ewing) 09/2011
1	Juvenile Myelomonocytic Leukemia 09/2011
1	Fatigue 09/2011
1	Fever (Fevers) 09/2011
1	Acute Promyelocytic Leukemia 05/2011
1	Pneumococcal Infections 03/2007
1	Lymphoma (Lymphomas) 11/2004

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2004
5	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2020
4	AntigensIBA 01/2018 - 11/2010
3	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2019
2	blinatumomabIBA 04/2021 - 07/2014
2	fosaprepitant FDA Link 01/2020 - 11/2019
2	AntiemeticsIBA 01/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2010
2	posaconazole FDA Link 07/2017 - 06/2017
2	EpitopesIBA 09/2015 - 02/2010
1	Interferon-betaIBA 02/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Clofarabine (Clolar)FDA Link 01/2022
1	CC ChemokinesIBA 01/2021
1	Decitabine FDA Link 01/2020
1	venetoclaxIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 11/2019
1	Vincristine (Oncovin)FDA LinkGeneric 11/2019
1	Asparaginase (Elspar)FDA Link 11/2019
1	Dimenhydrinate (DMH)FDA LinkGeneric 11/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	Peptide LibraryIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	DNA Ligase ATPIBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017
1	TabletsIBA 07/2017
1	Ferritins (Ferritin)IBA 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2015
1	S100 Proteins (S 100 Protein)IBA 10/2014
1	Immunoglobulins (Immunoglobulin)IBA 07/2014
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2013
1	Interleukin-2 (IL2)IBA 09/2011
1	Arsenic Trioxide (Trisenox)FDA Link 05/2011
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 05/2011
1	Ganciclovir (Cytovene)FDA LinkGeneric 07/2009
1	Cidofovir (Vistide)FDA Link 02/2007

Therapy/Procedure

16	Stem Cell Transplantation 01/2020 - 03/2004
15	Therapeutics 02/2022 - 03/2004
13	Transplantation 01/2022 - 05/2004
10	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2007
8	Immunotherapy 01/2021 - 03/2015
5	Drug Therapy (Chemotherapy) 01/2020 - 11/2010
2	Haploidentical Transplantation 08/2012 - 08/2010
1	Activities of Daily Living (ADL) 03/2022
1	Combined Modality Therapy 02/2022
1	Induction Chemotherapy 02/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018
1	Cell Transplantation 10/2014